Rheumatoid arthritis (RA) is an autoimmune inflammatory disease, of which the leading
cause of death is cardiovascular disease (CVD). The levels of total cholesterol (TC), low …

Background and objective Cardiovascular diseases (CVD) are the leading causes of death
in chronic inflammatory rheumatic diseases and are not solely explained by the increased …

The increased cardiovascular (CV) risk among patients with autoimmune rheumatic
diseases, such as arthritides and connective tissue diseases, has been extensively …

Objective In order to identify putative biomarkers in lipoprotein, we compared lipid and
lipoprotein properties between rheumatoid arthritis (RA) patients and control with similar …

Objective The present study tested the hypothesis that arterial stiffness will be elevated
across overall and specific inflammatory disorders compared with an inflammation-free …

Background: A decrease in serum paraoxonase (PON-1) and arylesterase (ARE) activity has
been reported in rheumatoid arthritis (RA) patients and linked to chronic inflammation and …

Hypercholesterolemia is one of the main risk factors for the development of atherosclerosis.
Among the various lipoprotein classes, however, high density lipoproteins (HDL) are …

Policosanol has been reported to improve blood pressure, lipid profile, and HDL
functionality via inhibition of cholesteryl ester transfer protein (CETP) both in vitro and in vivo …

Objectives. RA associates with increased cardiovascular disease (CVD) morbidity and
mortality due to accelerated atherosclerosis, attributed to both classical risk factors and …

Background: Methotrexate (MTX) treatment in rheumatoid arthritis (RA) has been associated
with lower cardiovascular risk compared to other disease-modifying antirheumatic drugs …